Stay updated on NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the history, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedFooter now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe funding-status notice at the top of the page was removed. The study record history content remains unchanged.SummaryDifference0.6%

- Check60 days agoChange DetectedThe New Screenshot shows updated styling and layout for the Record History page. There are no changes to study data, statuses, or other content.SummaryDifference0.1%

- Check88 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and guidance for users.SummaryDifference12%

- Check96 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.